Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors

Journal of Clinical Psychopharmacology

Volumn 31, Issue 3, 2011, Pages 341-344

  Beherec, Laurène ^a   Lambrey, Simon ^a,b   Quilici, Gwendoline ^a   Rosier, Antoine ^a   Falissard, Bruno ^c   Guillin, Olivier ^a,d  

^a CHS du Rouvray   (France)

^b Department of Psychiatry   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE ROUEN   (France)

Author keywords

behaviors; clozapine; pervasive developmental disorder

Indexed keywords

AMISULPRIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; CLOZAPINE; CYAMEMAZINE; DIAZEPAM; FLUOXETINE; FLUPENTIXOL; HALOPERIDOL; HIGH DENSITY LIPOPROTEIN; HYDROXYZINE; LEVOMEPROMAZINE; LOXAPINE; MACROGOL; METHYLPHENIDATE; MIANSERIN; MIRTAZAPINE; OLANZAPINE; PERICIAZINE; PIPAMPERONE; PROMETHAZINE; RISPERIDONE; SERTRALINE; TIAPRIDE; VALPROIC ACID;

ADULT; AGGRESSION; ARTICLE; AUTISM; AUTOMUTILATION; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CHILDHOOD AUTISM RATING SCALE; CLINICAL ARTICLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DISRUPTIVE BEHAVIOR; DRUG TOLERABILITY; ELECTROCARDIOGRAPHY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; METABOLIC SYNDROME X; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RATING SCALE; RETROSPECTIVE STUDY; SIDE EFFECT; TACHYCARDIA; WAIST CIRCUMFERENCE; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; CLOZAPINE; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES;

EID: 79955600656     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318218f4a1     Document Type: Article

References (23)

1. Levy SE, Mandell DS, Schultz RT. Autism. Lancet. 2009;374(9701): 1627-1638.
2. McDougle CJ, Scahill L, Aman MG, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry. 2005;162(6):1142-1148. (Pubitemid 40770697)
3. McDougle CJ, Stigler KA, Erickson CA, et al. Atypical antipsychotics in children with autistic and other pervasive developmental disorders. J Clin Psychiatry. 2008;69(suppl 4):15-20.
4. Parikh MS, Kolevzon A, Hollander E. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. J Child Adolesc Psychopharmacol. 2008;18(2):157-178. (Pubitemid 351591438)
5. Shea S, Turgay A, Carroll A, et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics. 2004;114(5):634-641.
6. McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347(5):314-321. (Pubitemid 34815353)
7. Marcus RN, Owen R, Kamen L, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009;48(11):1110-1119.
8. Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics. 2009;124(6):1533-1540.
9. Anderson LT, Campbell M, Adams P, et al. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. J Autism Dev Disord. 1989;19:227-239. (Pubitemid 19176531)
10. Anderson LT, Campbell M, Gregga DM, et al. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. Am J Psychiatry. 1884;141:1195-1202.
11. Campbell M, Armenteros JL, Malone RP, et al. Neuroleptic-related dyskinesias in autistic children: a prospective longitudinal study. J Am Acad Child Psychiatry. 1997;36:835-843. (Pubitemid 27250449)
12. Hollander E, Wasserman S, Swanson EN, et al. A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. J Child Adolesc Psychopharmacol. 2006;16(5):541-548. (Pubitemid 44737209)
13. Krakowski MI, Czobor P, Citrome L, et al. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 2006;63(6):622-629. (Pubitemid 43848293)
14. Leucht S, Wahlbeck K, Hamann J, et al. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet. 2003;361(9369): 1581-1589. (Pubitemid 36578993)
15. Chen NC, Bedair HS, McKay B, et al. Clozapine in the treatment of aggression in an adolescent with autistic disorder. J Clin Psychiatry. 2001;62:479-480. (Pubitemid 32717889)
16. Gobbi G, Pulvirenti L. Long term treatment with clozapine in an adult with autistic disorder accompanied by aggressive behaviour. J Psychiatr Neurosci. 2001;26:340-341. (Pubitemid 32912430)
17. Zuddas A, Ledda MG, Fratta A, et al. Clinical effects of clozapine on autistic disorder. Am J Psychiatry. 1996;153(5):738. (Pubitemid 26133642)
18. Lambrey S, Falissard B, Martin-Barrero M, et al. Effectiveness of clozapine for the treatment of aggressions in an adolescent with autistic disorder. J Child Adolesc Psychopharmacol. 2010;20(1):79-80.
19. Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24(5):659-685. (Pubitemid 24309810)
20. Lord C, Rutter M, Goode S, et al. Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord. 1989;19(2):185-212. (Pubitemid 19176529)
21. Schopler E, Reichler RJ, DeVellis RF, et al. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord. 1980;10(1):91-103. (Pubitemid 10050041)
22. Newcomer JW. Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry. 2007;68(suppl 4):8-13. (Pubitemid 46762118)
23. Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry. 2003;60(1):82-91. (Pubitemid 36070868)